Basler Kantonalbank Share Price

Certificat

BBYBKB

CH1225283022

Real-time Bid/Ask 05:07:54 27/06/2024 pm IST
82.48 CHF / 83.28 CHF -2.19% Intraday chart for Basler Kantonalbank
Current month-1.07%
1 month-3.28%
Date Price Change
26/24/26 84.74 -1.47%
25/24/25 86 +1.37%
24/24/24 84.84 +1.98%
21/24/21 83.19 +0.33%
20/24/20 82.92 +0.88%

Delayed Quote Swiss Exchange

Last update June 26, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
Issuer Basler Kantonalbank
BBYBKB
ISINCH1225283022
Date issued 30/01/2023
Strike 193.6
Maturity 30/01/2025 (218 Days)
Parity 1 : 1
Emission price 99.54 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 100.4 CHF
Lowest since issue 69.9 CHF
Spread 8 CHF
Spread %0.96%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
155.5 EUR
Average target price
184.4 EUR
Spread / Average Target
+18.61%
Consensus
  1. Stock Market
  2. Certificates
  3. BBYBKB Certificat